- JP-listed companies
- KANEKA CORPORATION
- Financials
- Net income margin (%)
KANEKA CORPORATION (4118)
Market cap
¥332.6B
P/E ratio
9.9x
Kaneka develops advanced materials, medical devices, solar technology, and nutrition products across four business units serving infrastructure, housing, healthcare, and food industries.
| Period End | Net income margin (%) | YoY (%) |
|---|---|---|
| Mar 31, 2025 | 3.3 | +2.18% |
| Mar 31, 2024 | 3.3 | +2.04% |
| Mar 31, 2023 | 3.2 | -20.56% |
| Mar 31, 2022 | 4 | +34.73% |
| Mar 31, 2021 | 3 | +15.65% |
| Mar 31, 2020 | 2.6 | -33.34% |
| Mar 31, 2019 | 3.9 | +0.96% |
| Mar 31, 2018 | 3.8 | -2.56% |
| Mar 31, 2017 | 3.9 | +3.70% |
| Mar 31, 2016 | 3.8 | +12.47% |
| Mar 31, 2015 | 3.4 | +162.25% |
| Mar 31, 2014 | 1.3 | -14.67% |
| Mar 31, 2013 | 1.5 | +252.81% |
| Mar 31, 2012 | 0.4 |